Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer von de Jong, Florus C, Rutten, Vera C, Zuiverloon, Tahlita C M, Theodorescu, Dan

Volltext

Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines von Zuiverloon, Tahlita C.M., de Jong, Florus C., Costello, James C., Theodorescu, Dan

Volltext

High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes von Rinaldetti, Sébastien, Zhou, Qiong, Abbott, Joshua M., de Jong, Florus C., Esquer, Hector, Costello, James C., Theodorescu, Dan, LaBarbera, Daniel V.

Volltext

Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy von Scholtes, Mathijs P, de Jong, Florus C, Zuiverloon, Tahlita C M, Theodorescu, Dan

Volltext

Reply to Chao Song’s Letter to the Editor re: Florus C. de Jong, Iris G. Iflé, Angelique C. van der Made, et al. A Genomic Urine Assay for Surveillance of Patients with Bladder Can... von de Jong, Florus C., Zuiverloon, Tahlita C.M., Boormans, Joost L.

Volltext

A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy von de Jong, Florus C., Iflé, Iris G., van der Made, Angelique C., Kooper, Denise, de Jong, Joep J., Franckena, Martine, Zuiverloon, Tahlita C.M., van Criekinge, Wim, Incrocci, Luca, Zwarthoff, Ellen C., Boormans, Joost L.

Volltext

Long-term efficacy of hyperthermic intravesical chemotherapy for BCG-unresponsive non-muscle invasive bladder cancer von Pijpers, Olga M, Hendricksen, Kees, Mostafid, Hugh, de Jong, Florus C, Rosier, Marloes, Mayor, Nikhil, de Jong, Joep J, Boormans, Joost L

Volltext

Molecular biomarkers of progression in non-muscle-invasive bladder cancer - beyond conventional risk stratification von Olislagers, Mitchell, de Jong, Florus C, Rutten, Vera C, Boormans, Joost L, Mahmoudi, Tokameh, Zuiverloon, Tahlita C M

Volltext

Sewage surveillance system using urological wastewater: Key to COVID-19 monitoring? von de Jong, Florus C., GeurtsvanKessel, Corine H., Molenkamp, Richard, Bangma, Chris H., Zuiverloon, Tahlita C.M.

Volltext

PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG von de Jong, Florus C., Kvikstad, Vebjørn, Hoedemaeker, Robert F., van der Made, Angelique C. J., van der Bosch, Thierry P., van Casteren, Niels J., van Kessel, Kim E. M., Zwarthoff, Ellen C., Boormans, Joost L., Zuiverloon, Tahlita C. M.

Volltext

Clinical Decision Making in Surveillance of Non-Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers von Zuiverloon, Tahlita C M, de Jong, Florus C, Theodorescu, Dan

Volltext

A Molecular Urine Assay to Detect Recurrences During Surveillance of High-Risk Non-Muscle Invasive Bladder Cancer von de Jong, Joep J., de Jong, Florus C., van der Made, Angelique C.J., van Casteren, Niels J., Roshani, Hossain, Oomens, Eric H.G.M., Pelger, Rob C.M., Steyerberg, Ewout W., Boormans, Joost L., Bangma, Chris H., Zuiverloon, Tahlita C.M., Zwarthoff, Ellen C.

Volltext

Precision Medicine in Bladder Cancer von de Jong, Florus C, Zuiverloon, Tahlita C.M, Theodorescu, Dan

Volltext

Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer von Tu, Megan M, Ng, Terry L, De Jong, Florus C, Zuiverloon, Tahlita C M, Fazzari, Francesco G T, Theodorescu, Dan

Volltext

T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at Diagnosis von de Jong, Florus C., Hoedemaeker, Robert F., Kvikstad, Vebjørn, Mensink, Jolien T M, de Jong, Joep J., Boevé, Egbert R., van der Schoot, Deric K E, Zwarthoff, Ellen C., Boormans, Joost L., Zuiverloon, Tahlita C M

Volltext

Abstract B06: Pathologic T1 substaging improves the identification of high-risk non-muscle invasive bladder cancer patients at risk of BCG failure von de Jong, Florus C., Hoedemaeker, Robert F., Mensink, Jolien T.M., Kvikstad, Vebjørn, Boevé, Egbert R., van der Schoot, Deric K.E., Zwarthoff, Ellen C., Zuiverloon, Tahlita C.M.

Volltext

Abstract 614: Transcriptomic analysis of BCG-treated T1HG bladder cancer patients identifies an EMT-basal subgroup with immune suppressive characteristics at high risk of BCG-failu... von De Jong, Florus C., Laajala, Teemu D., Hoedemaeker, Robert F., Rinaldetti, Sébastien, Mensink, Jolien T., Van der Made, Angelique C., Van der Schoot, Deric K., Boevé, Egbert R., Zwarthoff, Ellen C., Boormans, Joost L., Theodorescu, Dan, Costello, James C., Zuiverloon, Tahlita C.

Volltext

Abstract 615: Differential pathway analyses of BCG-treated T1HG bladder cancer using Philips OncoSignal: A pilot study von De Jong, Florus C., Laajala, Teemu D., Hoedemaeker, Robert F., Rinaldetti, Sébastien, Mensink, Jolien T., Van Der Made, Angelique C., Van der Schoot, Deric K., Boevé, Egbert R., Zwarthoff, Ellen C., Boormans, Joost L., Theodorescu, Dan, Costello, James C., Zuiverloon, Tahlita C.

Volltext

A genomic urine assay for surveillance of patients with bladder cancer treated with radiotherapy von de Jong, Florus C, Iflé, Iris G, van der Made, Angelique C, Kooper, Denise, de Jong, Joep J, Franckena, Martine, Zuiverloon, Tahlita C.M, Van Criekinge, Wim, Incrocci, Luca, Zwarthoff, Ellen C, Boormans, Joost L

Volltext

Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer

Volltext